Robin E Smith

Title: Innovations of Robin E Smith

Introduction

Robin E Smith is a notable inventor based in Murrumbeena, Australia. He has made significant contributions to the field of genetic research, particularly in the area of glucocorticoid dehydrogenases. With a total of two patents to his name, his work has implications for both diagnostics and treatment in medical science.

Latest Patents

Smith's latest patents focus on genetic sequences encoding glucocorticoid dehydrogenases. These inventions relate to nucleic acid molecules that encode a recombinant NAD+ dependent glucocorticoid dehydrogenase, specifically 11 .beta.-hydroxysteroid dehydrogenase-2 (11 .beta.HSD2). When expressed in prokaryotic or eukaryotic cells, these nucleic acid molecules can be used to assay for potential agonists or antagonists of glucocorticoid dehydrogenase activity. Furthermore, his inventions include immunoreactive molecules to NAD+ dependent glucocorticoid dehydrogenase, which serve as the foundation for new diagnostic agents. These agents can be utilized in diagnosing and treating hypertension, as well as predicting outcomes in in vitro fertilization and embryo transfer procedures.

Career Highlights

Robin E Smith is affiliated with the Baker Medical Research Institute, where he continues to advance his research and innovations. His work has garnered attention for its potential applications in the medical field, particularly in understanding and treating conditions related to glucocorticoid metabolism.

Collaborations

Some of his notable coworkers include John W Funder and Anthony L Albiston. Their collaborative efforts contribute to the ongoing research and development in the field of glucocorticoid dehydrogenases.

Conclusion

Robin E Smith's contributions to genetic research and his innovative patents highlight the importance of scientific advancements in medicine. His work not only enhances our understanding of glucocorticoid dehydrogenases but also paves the way for new diagnostic and therapeutic approaches.